openPR Logo
Press release

Biopharmaceutical Contract Manufacturing Market to enjoy ‘explosive growth’ to 2026

01-28-2019 03:40 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Biotechnology

Global Biopharmaceutical Contract Manufacturing Market

Global Biopharmaceutical Contract Manufacturing Market

Contract manufacturing organizations (CMOs) provide wide range of manufacturing services, which include contract packaging, quality testing, and development service to pharmaceutical and biotechnology industries. Biopharmaceutical companies prefer CMOs due to complexity in manufacturing process of biomolecules, as they consists of different shape, size, and behavior with significantly complex process than pharmaceutical drugs. Contract manufacturing organizations provide services from development of biologics to commercial scale production. Few companies also provide cell line development, fermentation, process optimization, and analytical characterization. Improved efficiency, weak product pipeline, and increasing price pressure is expected to favor the growth of biopharmaceutical contract manufacturing market in near future.

Download PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/1077

Increasing outsourcing services in biopharmaceutical industry is expected to fuel the growth of biopharmaceutical contract manufacturing market:

Pelican Therapeutics and subsidiary of Heat Biologics entered into a manufacturing agreement with KBI Biopharma in September, 2017. As per the agreement, KBI biopharma will provide development and manufacturing service under biopharmaceutical contract development and manufacturing organization (CDMO) for cGMP production of an antibody (PTX-35) and a fusion protein (PTX-15). Pelican Therapeutics intends to develop immunotherapy drugs by mimicking the production of antigen-specific T-cells. In May 2016, pelican received grant around US$ 15.2 million by Cancer Prevention and Research Institute of Texas (CPRIT) to its manufacturing efforts in immunotherapies for lung, pancreatic, lymphoma, prostate, and ovarian cancers.

Ajinomoto Althea, Inc., announced a GMP production suite in newly established High Potency Products (HPP) manufacturing site located in San Diego, California, in September 2017. Currently, Althea is offering process development and analytical services to the clients and from November 2017, the company will provide facilities for GMP manufacturing of bioconjugation and complex formulation. Apart from this services, Althea is aiming to provide full manufacturing services including fill-and-finish, which will start off in 2018.

Reducing cost and focusing on core strengths is expected to fuel the growth of biopharmaceutical contract manufacturing market:L

According to the Journal of Pharmaceutical Manufacturing in 2017, major factors driving the growth of biopharmaceutical contract manufacturing market include minimizing risk by outsourcing with other biopharma to achieve efficient product in minimum time interval, switching over the large biopharma companies to strengthen the weak pipeline product, and to cut off the costs of product development without risking financial investments. Moreover, CMOs offer services to companies lacking the capability to develop formula or product.

The key players in biopharmaceutical contract manufacturing market include Lonza Group Ltd., ProBioGen AG, Boehringher Ingelheim, BIOMEVA GmbH, Celonic GmbH, Sandoz, Fujifilm Diosynth Biotechnology, and Rentschler Biotechnologie.

For More Information @ https://www.coherentmarketinsights.com/ongoing-insight/biopharmaceutical-contract-manufacturing-market-1077

Global Biopharmaceutical Contract Manufacturing Market Taxonomy:

On the basis of contract type, product type, and therapeutic application, global biopharmaceutical contract manufacturing market is segmented into:

By Contract Type:
• Active Pharmaceutical Ingredient (API)
• Fill-And-Finished

By Product Type:
• Interferons
• Monoclonal Antibodies
• Recombinant Hormone
• Proteins
• Vaccines
• Vitamins
• Insulin
• Others

By Therapeutic Applications:
• Oncology
• Autoimmune Diseases
• Metabolic Diseases
• Cardiovascular Diseases
• Neurology
• Infectious Diseases
• Others

Request For Customization @ https://www.coherentmarketinsights.com/insight/request-customization/1077

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biopharmaceutical Contract Manufacturing Market to enjoy ‘explosive growth’ to 2026 here

News-ID: 1538953 • Views:

More Releases from Coherent Market Insights - Biotechnology

Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 Period till 2027 | Medtronic Plc, Hill-Rom Holdings, iRhythm Technologies
Wearable Patch Market 2030 Emerging Trends and Global Demand During the COVID-19 …
Coherent Market Insights published a report, titled,"Wearable Patch Market, by Technology (Connected and Regular), by Application (Monitoring, Drug Delivery, and Diagnostics), by End User (Healthcare and Fitness & Sports), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027." Wearable patches are used for monitoring and diagnosis of chronic diseases. Increasing prevalence of diseases such as atrial
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast Period 2017 - 2025 And The Top Competitors Are Crown Bioscience, ProSpec Tany TechnoGene, BPS Bioscience, Sigma Aldrich Company, Novoprotein Scientific
Recombinant Protein Market To Witness Robust Expansion Throughout The Forecast P …
Recombinant proteins have immense potential in cancer therapy research and development. For instance, growth factors, immune checkpoint, and cell damage & oxidative stress proteins (preclinical stage) are utilized from recombinant proteins category for cancer therapy research. Increased understanding of oncogenic signaling pathways and proteins involved in the same has increased the targeting ways, wherein, recombinant proteins such as immune checkpoint, growth factors, and antibodies are used. These proteins are used
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players Biocon, Pfizer Inc., F. Hoffmann-La Roche Ltd, Amgen Inc., Kyowa Pharmaceutical Industry Co. Ltd, Boehringer Ingelheim GmbH, AstraZeneca, Novartis AG, and Merck & Co
Biosimilar Pipeline Analysis Market Outlook 2019: Rapidly Develop by key Players …
Biosimilar market is under the initial phase of development, they are used for the treatment of various disorders such as autoimmune disease, cancer as per National Institute of Health 2012 report, there were more than 23.5 million people living with autoimmune disease in the U.S. and low pricing of biosimilar drugs make them affordable for people. The same mechanism of action provides effective treatment for disease along with increased awareness
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., Bard1 Life Sciences Limited, Bio-Rad Laboratories, Abbott Laboratories, Becton, Dickinson and Company, Merck & Co., Inc., Qiagen N.V., and Thermo Fisher Scientific Inc
Cancer Biomarkers Market Rapid Growth 2019 by leading players BioMerieux S.A., B …
The global cancer biomarkers market is projected to witness significant growth over the forecast period, owing to rising incidence and prevalence of various cancer types, including breast cancer, lung cancer, kidney cancer, liver cancer, prostate cancer, and among others. Moreover, other factors impacting growth of cancer biomarkers market includes rising research and development activities in developing cancer biomarker and rising demand for personalized medicine in cancer therapies. Free Request Sample Copy

All 5 Releases


More Releases for Contract

Pharmaceutical Contract Manufacturing and Contract Market 2021 | Detailed Report
The Pharmaceutical Contract Manufacturing and Contract research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Pharmaceutical Contract Manufacturing and Contract research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving
Contract Staffing Company India | Contract Staffing Services Mumbai & Banglore - …
Characterised with stringent legislation, fluctuating demand, a paucity of employable talent and market unpredictability, the modern business landscape offers a convincing rationale to employ a contract workforce in the business. You may not want to compromise on profits when you can adopt a 'just-in-time' strategy to bring the best workforce on-board using a contract staffing approach. With our cutting-edge contract staffing services, you can have all in one shot: An
Global Pharmaceutical Contract Manufacturing & Contract Market 2018, Manufacture …
Qyresearchreports include new market research report "Global Pharmaceutical Contract Manufacturing & Contract Market Size, Status and Forecast 2025" to its huge collection of research reports. This report studies the global Pharmaceutical Contract Manufacturing & Contract market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Pharmaceutical Contract Manufacturing & Contract market by companies, region, type and end-use industry. The report on the global Pharmaceutical Contract
Pharmaceutical Contract Manufacturing & Contract Market Excellent Growth by 2025
The qualitative research study conducted by HTF MI titled “Global Pharmaceutical Contract Manufacturing & Contract Market Size, Status and Forecast 2025” provides primary Data, surveys, Scope of the Product and vendor briefings. The market dynamic forces have been determined after conducting a detailed study of the Global Pharmaceutical Contract Manufacturing & Contract market. The study provides forecasts for Pharmaceutical Contract Manufacturing & Contract investments till 2022. If you are involved
Global Enterprise Contract Management Market 2018 Key Players: Agiloft Contract …
Enterprise Contract Management Market: WiseGuyReports.com adds “Enterprise Contract Management Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2023”reports to its database. Executive Summary The global enterprise contract management market to grow from USD 1085.53 million in 2016 to USD 3166.66 million by 2023, at a Compound Annual Growth Rate (CAGR) of 16.53%. The year 2016 has been considered as the base year, while the forecast period is up-to 2023. The major
Contract Management Software Market 2018 Global Analysis By key Players : Contra …
This report studies the global Contract Management Software market, analyzes and researches the Contract Management Software development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Contract Advantage Trackado Symfact Icertis Contract Management A1 Tracker Interneer Intellect OneSoft Connect Rosmiman IWMS Universal Contract Manager Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1373464-global-contract-management-software-market-size-status-and-forecast-2022 Freshservice Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Contract Management Software can